Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope

Jean Luc Perfettini, Maria Castedo, Roberta Nardacci, Fabiola Ciccosanti, Patricia Boya, Thomas Roumier, Nathanael Larochette, Mauro Piacentini, Guido Kroemer

Research output: Contribution to journalArticle

109 Citations (Scopus)

Abstract

The proapoptotic activity of the transcription factor p53 critically depends on the phosphorylation of serine 46 (p53S46P). Here, we show that syncytia containing p53S46P could be detected in lymph node biopsies from human immunodeficiency virus (HIV)-1 carriers, in the brain of patients with HIV-1-associated dementia and in cocultures of HeLa expressing the HIV-1 envelope glycoprotein complex (Env) with HeLa cells expressing CD4. In this latter model, cell death was the result of a sequential process involving cell fusion, nuclear fusion (karyogamy), phosphorylation of serine 15 (p53S15P), later on serine 46 (p53S46P), and transcription of p53 target genes. Cytoplasmic p38 mitogen-activated protein kinase (MAPK) was found to undergo an activating phosphorylation (p38T180/Y182P [p38 with phosphorylated threonine 180 and tyrosine 182]) before karyogamy and to translocate into karyogamic nuclei. p38T180/Y182P colocalized and coimmunoprecipitated with p53S46P. Recombinant p38 phosphorylated recombinant p53 on serine 46 in vitro. Inhibition of p38 MAPK by pharmacological inhibitors, dominant-negative p38, or small interfering RNA, suppressed p53S46P (but not p53S15P), the expression of p53-inducible genes, the conformational activation of proapoptotic Bax and Bak, the release of cytochrome c from mitochondria, and consequent apoptosis. p38T180/Y182P was also detected in HIV-1-induced syncytia, in vivo, in patients' lymph nodes and brains. Dominant-negative MKK3 or MKK6 inhibited syncytial activation of p38, p53S46P, and apoptosis. Altogether, these findings indicate that p38 MAPK-mediated p53 phosphorylation constitutes a critical step of Env-induced apoptosis.

Original languageEnglish
Pages (from-to)279-289
Number of pages11
JournalJournal of Experimental Medicine
Volume201
Issue number2
DOIs
Publication statusPublished - Jan 17 2005

Fingerprint

p38 Mitogen-Activated Protein Kinases
Threonine
Serine
Tyrosine
HIV-1
Apoptosis
p53 Genes
Giant Cells
Nuclear Fusion
Lymph Nodes
env Gene Products
Cell Fusion
Brain
Protein Kinase Inhibitors
Coculture Techniques
Cytochromes c
HeLa Cells
Small Interfering RNA
Transcriptional Activation
Dementia

ASJC Scopus subject areas

  • Immunology

Cite this

Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope. / Perfettini, Jean Luc; Castedo, Maria; Nardacci, Roberta; Ciccosanti, Fabiola; Boya, Patricia; Roumier, Thomas; Larochette, Nathanael; Piacentini, Mauro; Kroemer, Guido.

In: Journal of Experimental Medicine, Vol. 201, No. 2, 17.01.2005, p. 279-289.

Research output: Contribution to journalArticle

Perfettini, Jean Luc ; Castedo, Maria ; Nardacci, Roberta ; Ciccosanti, Fabiola ; Boya, Patricia ; Roumier, Thomas ; Larochette, Nathanael ; Piacentini, Mauro ; Kroemer, Guido. / Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope. In: Journal of Experimental Medicine. 2005 ; Vol. 201, No. 2. pp. 279-289.
@article{2fd186506d2940d4ad1c788e9ca2d685,
title = "Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope",
abstract = "The proapoptotic activity of the transcription factor p53 critically depends on the phosphorylation of serine 46 (p53S46P). Here, we show that syncytia containing p53S46P could be detected in lymph node biopsies from human immunodeficiency virus (HIV)-1 carriers, in the brain of patients with HIV-1-associated dementia and in cocultures of HeLa expressing the HIV-1 envelope glycoprotein complex (Env) with HeLa cells expressing CD4. In this latter model, cell death was the result of a sequential process involving cell fusion, nuclear fusion (karyogamy), phosphorylation of serine 15 (p53S15P), later on serine 46 (p53S46P), and transcription of p53 target genes. Cytoplasmic p38 mitogen-activated protein kinase (MAPK) was found to undergo an activating phosphorylation (p38T180/Y182P [p38 with phosphorylated threonine 180 and tyrosine 182]) before karyogamy and to translocate into karyogamic nuclei. p38T180/Y182P colocalized and coimmunoprecipitated with p53S46P. Recombinant p38 phosphorylated recombinant p53 on serine 46 in vitro. Inhibition of p38 MAPK by pharmacological inhibitors, dominant-negative p38, or small interfering RNA, suppressed p53S46P (but not p53S15P), the expression of p53-inducible genes, the conformational activation of proapoptotic Bax and Bak, the release of cytochrome c from mitochondria, and consequent apoptosis. p38T180/Y182P was also detected in HIV-1-induced syncytia, in vivo, in patients' lymph nodes and brains. Dominant-negative MKK3 or MKK6 inhibited syncytial activation of p38, p53S46P, and apoptosis. Altogether, these findings indicate that p38 MAPK-mediated p53 phosphorylation constitutes a critical step of Env-induced apoptosis.",
author = "Perfettini, {Jean Luc} and Maria Castedo and Roberta Nardacci and Fabiola Ciccosanti and Patricia Boya and Thomas Roumier and Nathanael Larochette and Mauro Piacentini and Guido Kroemer",
year = "2005",
month = "1",
day = "17",
doi = "10.1084/jem.20041502",
language = "English",
volume = "201",
pages = "279--289",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "2",

}

TY - JOUR

T1 - Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope

AU - Perfettini, Jean Luc

AU - Castedo, Maria

AU - Nardacci, Roberta

AU - Ciccosanti, Fabiola

AU - Boya, Patricia

AU - Roumier, Thomas

AU - Larochette, Nathanael

AU - Piacentini, Mauro

AU - Kroemer, Guido

PY - 2005/1/17

Y1 - 2005/1/17

N2 - The proapoptotic activity of the transcription factor p53 critically depends on the phosphorylation of serine 46 (p53S46P). Here, we show that syncytia containing p53S46P could be detected in lymph node biopsies from human immunodeficiency virus (HIV)-1 carriers, in the brain of patients with HIV-1-associated dementia and in cocultures of HeLa expressing the HIV-1 envelope glycoprotein complex (Env) with HeLa cells expressing CD4. In this latter model, cell death was the result of a sequential process involving cell fusion, nuclear fusion (karyogamy), phosphorylation of serine 15 (p53S15P), later on serine 46 (p53S46P), and transcription of p53 target genes. Cytoplasmic p38 mitogen-activated protein kinase (MAPK) was found to undergo an activating phosphorylation (p38T180/Y182P [p38 with phosphorylated threonine 180 and tyrosine 182]) before karyogamy and to translocate into karyogamic nuclei. p38T180/Y182P colocalized and coimmunoprecipitated with p53S46P. Recombinant p38 phosphorylated recombinant p53 on serine 46 in vitro. Inhibition of p38 MAPK by pharmacological inhibitors, dominant-negative p38, or small interfering RNA, suppressed p53S46P (but not p53S15P), the expression of p53-inducible genes, the conformational activation of proapoptotic Bax and Bak, the release of cytochrome c from mitochondria, and consequent apoptosis. p38T180/Y182P was also detected in HIV-1-induced syncytia, in vivo, in patients' lymph nodes and brains. Dominant-negative MKK3 or MKK6 inhibited syncytial activation of p38, p53S46P, and apoptosis. Altogether, these findings indicate that p38 MAPK-mediated p53 phosphorylation constitutes a critical step of Env-induced apoptosis.

AB - The proapoptotic activity of the transcription factor p53 critically depends on the phosphorylation of serine 46 (p53S46P). Here, we show that syncytia containing p53S46P could be detected in lymph node biopsies from human immunodeficiency virus (HIV)-1 carriers, in the brain of patients with HIV-1-associated dementia and in cocultures of HeLa expressing the HIV-1 envelope glycoprotein complex (Env) with HeLa cells expressing CD4. In this latter model, cell death was the result of a sequential process involving cell fusion, nuclear fusion (karyogamy), phosphorylation of serine 15 (p53S15P), later on serine 46 (p53S46P), and transcription of p53 target genes. Cytoplasmic p38 mitogen-activated protein kinase (MAPK) was found to undergo an activating phosphorylation (p38T180/Y182P [p38 with phosphorylated threonine 180 and tyrosine 182]) before karyogamy and to translocate into karyogamic nuclei. p38T180/Y182P colocalized and coimmunoprecipitated with p53S46P. Recombinant p38 phosphorylated recombinant p53 on serine 46 in vitro. Inhibition of p38 MAPK by pharmacological inhibitors, dominant-negative p38, or small interfering RNA, suppressed p53S46P (but not p53S15P), the expression of p53-inducible genes, the conformational activation of proapoptotic Bax and Bak, the release of cytochrome c from mitochondria, and consequent apoptosis. p38T180/Y182P was also detected in HIV-1-induced syncytia, in vivo, in patients' lymph nodes and brains. Dominant-negative MKK3 or MKK6 inhibited syncytial activation of p38, p53S46P, and apoptosis. Altogether, these findings indicate that p38 MAPK-mediated p53 phosphorylation constitutes a critical step of Env-induced apoptosis.

UR - http://www.scopus.com/inward/record.url?scp=13244260955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13244260955&partnerID=8YFLogxK

U2 - 10.1084/jem.20041502

DO - 10.1084/jem.20041502

M3 - Article

VL - 201

SP - 279

EP - 289

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 2

ER -